The global DNA Vaccines market size was valued at USD 4776.4 million in 2022 and is forecast to a readjusted size of USD 7856.9 million by 2029 with a CAGR of 7.4% during review period.
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunological and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
This report is a detailed and comprehensive analysis for global DNA Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global DNA Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global DNA Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global DNA Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global DNA Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DNA Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DNA Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Recombinant Protein Vaccine
Gene-Based Vaccine
Human
Animal
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe DNA Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DNA Vaccines, with price, sales, revenue and global market share of DNA Vaccines from 2018 to 2023.
Chapter 3, the DNA Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DNA Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and DNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of DNA Vaccines.
Chapter 14 and 15, to describe DNA Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of DNA Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DNA Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Recombinant Protein Vaccine
1.3.3 Gene-Based Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global DNA Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Human
1.4.3 Animal
1.5 Global DNA Vaccines Market Size & Forecast
1.5.1 Global DNA Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global DNA Vaccines Sales Quantity (2018-2029)
1.5.3 Global DNA Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck DNA Vaccines Product and Services
2.1.4 Merck DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DNA Vaccines Product and Services
2.2.4 GSK DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi DNA Vaccines Product and Services
2.3.4 Sanofi DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Zoties
2.4.1 Zoties Details
2.4.2 Zoties Major Business
2.4.3 Zoties DNA Vaccines Product and Services
2.4.4 Zoties DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zoties Recent Developments/Updates
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco DNA Vaccines Product and Services
2.5.4 Elanco DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Elanco Recent Developments/Updates
2.6 Boehringer-Ingelheim
2.6.1 Boehringer-Ingelheim Details
2.6.2 Boehringer-Ingelheim Major Business
2.6.3 Boehringer-Ingelheim DNA Vaccines Product and Services
2.6.4 Boehringer-Ingelheim DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boehringer-Ingelheim Recent Developments/Updates
2.7 Indian Immunologicals
2.7.1 Indian Immunologicals Details
2.7.2 Indian Immunologicals Major Business
2.7.3 Indian Immunologicals DNA Vaccines Product and Services
2.7.4 Indian Immunologicals DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Indian Immunologicals Recent Developments/Updates
2.8 Plumbline Life Sciences
2.8.1 Plumbline Life Sciences Details
2.8.2 Plumbline Life Sciences Major Business
2.8.3 Plumbline Life Sciences DNA Vaccines Product and Services
2.8.4 Plumbline Life Sciences DNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Plumbline Life Sciences Recent Developments/Updates
3 Competitive Environment: DNA Vaccines by Manufacturer
3.1 Global DNA Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global DNA Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global DNA Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of DNA Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 DNA Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 DNA Vaccines Manufacturer Market Share in 2022
3.5 DNA Vaccines Market: Overall Company Footprint Analysis
3.5.1 DNA Vaccines Market: Region Footprint
3.5.2 DNA Vaccines Market: Company Product Type Footprint
3.5.3 DNA Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global DNA Vaccines Market Size by Region
4.1.1 Global DNA Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global DNA Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global DNA Vaccines Average Price by Region (2018-2029)
4.2 North America DNA Vaccines Consumption Value (2018-2029)
4.3 Europe DNA Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific DNA Vaccines Consumption Value (2018-2029)
4.5 South America DNA Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa DNA Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global DNA Vaccines Sales Quantity by Type (2018-2029)
5.2 Global DNA Vaccines Consumption Value by Type (2018-2029)
5.3 Global DNA Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global DNA Vaccines Sales Quantity by Application (2018-2029)
6.2 Global DNA Vaccines Consumption Value by Application (2018-2029)
6.3 Global DNA Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America DNA Vaccines Sales Quantity by Type (2018-2029)
7.2 North America DNA Vaccines Sales Quantity by Application (2018-2029)
7.3 North America DNA Vaccines Market Size by Country
7.3.1 North America DNA Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America DNA Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe DNA Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe DNA Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe DNA Vaccines Market Size by Country
8.3.1 Europe DNA Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe DNA Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific DNA Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific DNA Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific DNA Vaccines Market Size by Region
9.3.1 Asia-Pacific DNA Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific DNA Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America DNA Vaccines Sales Quantity by Type (2018-2029)
10.2 South America DNA Vaccines Sales Quantity by Application (2018-2029)
10.3 South America DNA Vaccines Market Size by Country
10.3.1 South America DNA Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America DNA Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa DNA Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa DNA Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa DNA Vaccines Market Size by Country
11.3.1 Middle East & Africa DNA Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa DNA Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 DNA Vaccines Market Drivers
12.2 DNA Vaccines Market Restraints
12.3 DNA Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of DNA Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of DNA Vaccines
13.3 DNA Vaccines Production Process
13.4 DNA Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DNA Vaccines Typical Distributors
14.3 DNA Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global DNA Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global DNA Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck DNA Vaccines Product and Services
Table 6. Merck DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK DNA Vaccines Product and Services
Table 11. GSK DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi DNA Vaccines Product and Services
Table 16. Sanofi DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Zoties Basic Information, Manufacturing Base and Competitors
Table 19. Zoties Major Business
Table 20. Zoties DNA Vaccines Product and Services
Table 21. Zoties DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zoties Recent Developments/Updates
Table 23. Elanco Basic Information, Manufacturing Base and Competitors
Table 24. Elanco Major Business
Table 25. Elanco DNA Vaccines Product and Services
Table 26. Elanco DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Elanco Recent Developments/Updates
Table 28. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer-Ingelheim Major Business
Table 30. Boehringer-Ingelheim DNA Vaccines Product and Services
Table 31. Boehringer-Ingelheim DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Boehringer-Ingelheim Recent Developments/Updates
Table 33. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 34. Indian Immunologicals Major Business
Table 35. Indian Immunologicals DNA Vaccines Product and Services
Table 36. Indian Immunologicals DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Indian Immunologicals Recent Developments/Updates
Table 38. Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors
Table 39. Plumbline Life Sciences Major Business
Table 40. Plumbline Life Sciences DNA Vaccines Product and Services
Table 41. Plumbline Life Sciences DNA Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Plumbline Life Sciences Recent Developments/Updates
Table 43. Global DNA Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global DNA Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global DNA Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 46. Market Position of Manufacturers in DNA Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and DNA Vaccines Production Site of Key Manufacturer
Table 48. DNA Vaccines Market: Company Product Type Footprint
Table 49. DNA Vaccines Market: Company Product Application Footprint
Table 50. DNA Vaccines New Market Entrants and Barriers to Market Entry
Table 51. DNA Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global DNA Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global DNA Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global DNA Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global DNA Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global DNA Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 57. Global DNA Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 58. Global DNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global DNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global DNA Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global DNA Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global DNA Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 63. Global DNA Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 64. Global DNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global DNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global DNA Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global DNA Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global DNA Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 69. Global DNA Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 70. North America DNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America DNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America DNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America DNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America DNA Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America DNA Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America DNA Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America DNA Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe DNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe DNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe DNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe DNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe DNA Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe DNA Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe DNA Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe DNA Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific DNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific DNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific DNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific DNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific DNA Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific DNA Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific DNA Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific DNA Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America DNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America DNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America DNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America DNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America DNA Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America DNA Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America DNA Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America DNA Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa DNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa DNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa DNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa DNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa DNA Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa DNA Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa DNA Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa DNA Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 110. DNA Vaccines Raw Material
Table 111. Key Manufacturers of DNA Vaccines Raw Materials
Table 112. DNA Vaccines Typical Distributors
Table 113. DNA Vaccines Typical Customers
List of Figures
Figure 1. DNA Vaccines Picture
Figure 2. Global DNA Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global DNA Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Recombinant Protein Vaccine Examples
Figure 5. Gene-Based Vaccine Examples
Figure 6. Global DNA Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global DNA Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Human Examples
Figure 9. Animal Examples
Figure 10. Global DNA Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global DNA Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global DNA Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global DNA Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 14. Global DNA Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global DNA Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of DNA Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 DNA Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 DNA Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global DNA Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global DNA Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America DNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe DNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific DNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America DNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa DNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global DNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global DNA Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global DNA Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global DNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global DNA Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global DNA Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America DNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America DNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America DNA Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America DNA Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe DNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe DNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe DNA Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe DNA Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific DNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific DNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific DNA Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific DNA Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America DNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America DNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America DNA Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America DNA Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa DNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa DNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa DNA Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa DNA Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa DNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. DNA Vaccines Market Drivers
Figure 73. DNA Vaccines Market Restraints
Figure 74. DNA Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of DNA Vaccines in 2022
Figure 77. Manufacturing Process Analysis of DNA Vaccines
Figure 78. DNA Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
